AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

Free azn Stock Alerts

$68.73

-0.20 (-0.29%)

(As of 04/15/2024 ET)

Compare

Upcoming Earnings Date: Apr. 25
Before Market Opens
Confirmed
Actual EPS (Feb. 8): $0.73 Missed By -$0.01
Consensus EPS (Feb. 8): $0.74

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

AZN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AZN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Gold Safe Exchange

Trump’s “Tax Free” Retirement Strategy

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

AstraZeneca Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	$0.87	$0.96	$0.92
Q2 2024	2	$0.99	$1.01	$1.00
Q3 2024	2	$1.05	$1.05	$1.05
Q4 2024	2	$1.09	$1.10	$1.10
FY 2024	8	$4.00	$4.12	$4.06
Q1 2025	1	$1.06	$1.06	$1.06
Q2 2025	1	$1.15	$1.15	$1.15
Q3 2025	1	$1.18	$1.18	$1.18
Q4 2025	1	$1.26	$1.26	$1.26
FY 2025	4	$4.65	$4.65	$4.65
Q1 2026	1	$1.23	$1.23	$1.23

AZN Earnings Date and Information

AstraZeneca last issued its quarterly earnings data on February 8th, 2024. The reported $0.73 EPS for the quarter, missing analysts' consensus estimates of $0.74 by $0.01. The business earned $12.02 billion during the quarter, compared to analysts' expectations of $12.07 billion. Its revenue for the quarter was up 7.3% compared to the same quarter last year. AstraZeneca has generated $1.92 earnings per share over the last year ($1.92 diluted earnings per share) and currently has a price-to-earnings ratio of 35.8. Earnings for AstraZeneca are expected to grow by 15.92% in the coming year, from $4.02 to $4.66 per share. AstraZeneca has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024.

AstraZeneca Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
4/25/2024 Confirmed)	-	-	-	-	-	-	-
2/8/2024	Q4 2023	$0.74	$0.73	($0.01)	$1.15	$12.07 billion	$12.02 billion
11/8/2023	Q3 2023	$0.84	$0.87	+$0.03	$1.30	$11.55 billion	$11.49 billion
7/28/2023	Q2 2023	$0.97	$1.08	+$0.11	$1.57	$11.06 billion	$11.42 billion
4/27/2023	Q1 2023	$0.86	$0.96	+$0.10	$1.34	$10.80 billion	$10.88 billion
2/9/2023	Q4 2022	$0.68	$0.69	+$0.01	$1.09	$11.40 billion	$11.21 billion
11/10/2022	Q3 2022	$0.77	$0.84	+$0.07	$1.15	$10.98 billion	$10.98 billion
Get the Latest News and Ratings for AZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.
11/10/2022	Q3 2022	$0.77	$0.84	+$0.07	$1.15	$10.98 billion	$10.98 billion
7/29/2022	Q2 2022	$0.78	$0.86	+$0.08	$1.60	$10.44 billion	$10.77 billion
7/29/2022	Q2 2022	$0.78	$0.86	+$0.08	$1.60	$10.44 billion	$10.77 billion
4/29/2022	Q1 2022	$0.86	$0.95	+$0.09	$1.77	$11.19 billion	$11.39 billion
4/29/2022	Q1 2022	$0.86	$0.95	+$0.09	$1.77	$11.19 billion	$11.39 billion
4/29/2022	Q1 2022	$0.86	$0.95	+$0.09	$1.77	$10.96 billion	$11.39 billion
2/10/2022	Q4 2021	$0.77	$0.84	+$0.07	$1.79	$11.04 billion	$12.01 billion
2/10/2022	Q4 2021	$0.77	$0.84	+$0.07	$1.79	$11.04 billion	$12.01 billion
2/10/2022	Q4 2021	$0.77	$0.84	+$0.07	$1.79	$11.06 billion	$11.50 billion
11/12/2021	Q3 2021	$0.63	$0.54	($0.09)	$1.63	$9.82 billion	$9.87 billion
11/12/2021	Q3 2021	$0.63	$0.54	($0.09)	$1.63	$9.82 billion	$9.87 billion
11/11/2021	Q3 2021	$0.62	$0.54	($0.08)	$1.63	$9.58 billion	$9.74 billion
7/29/2021	Q2 2021	$0.45	$0.45	-	$0.69	$7.79 billion	$8.22 billion
7/29/2021	Q2 2021	$0.45	$0.45	-	$0.69	$7.79 billion	$8.22 billion
7/28/2021	Q2 2021	$0.43	$0.45	+$0.02	$0.69	$7.79 billion	$8.22 billion
4/30/2021	Q1 2021	$0.71	$0.81	+$0.10	$1.03	$7.17 billion	$7.32 billion
4/30/2021	Q1 2021	$0.71	$0.81	+$0.10	$1.03	$7.17 billion	$7.32 billion
4/29/2021	Q1 2021	$0.71	$0.82	+$0.11	$1.03	$7.15 billion	$7.32 billion

AstraZeneca Earnings - Frequently Asked Questions

When is AstraZeneca's earnings date?: AstraZeneca has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on AZN's earnings history.
Did AstraZeneca beat their earnings estimates last quarter?: In the previous quarter, AstraZeneca (NASDAQ:AZN) missed the analysts' consensus estimate of $0.74 by $0.01 with a reported earnings per share (EPS) of $0.73. Learn more on analysts' earnings estimate vs. AZN's actual earnings.
How can I listen to AstraZeneca's earnings conference call?: The conference call for AstraZeneca's latest earnings report can be listened to online. Listen to Conference Call
How can I read AstraZeneca's conference call transcript?: The conference call transcript for AstraZeneca's latest earnings report can be read online. Read Transcript

How much revenue does AstraZeneca generate each year?: AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $45.81 billion.
How much profit does AstraZeneca generate each year?: AstraZeneca (NASDAQ:AZN) has a recorded net income of $5.96 billion. AZN has generated $1.92 earnings per share over the last four quarters.
What is AstraZeneca's price-to-earnings ratio?: AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 35.80 and a forward price-to-earnings ratio of 17.10. The price/earnings-to-growth ratio is 1.26.
What is AstraZeneca's EPS forecast for next year?: AstraZeneca's earnings are expected to grow from $4.02 per share to $4.66 per share in the next year, which is a 15.92% increase.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:AZN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts

AZN Earnings Estimates and Actuals by Quarter

AZN Estimated and Actual Revenue by Quarter

AstraZeneca Analyst EPS Estimates

AZN Earnings Date and Information

AstraZeneca Earnings History by Quarter

AstraZeneca Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

AstraZeneca (AZN) Earnings Date, Estimates & Call Transcripts

Earnings Summary

AZN Earnings Estimates and Actuals by Quarter

AZN Estimated and Actual Revenue by Quarter

AstraZeneca Analyst EPS Estimates

AZN Earnings Date and Information

AstraZeneca Earnings History by Quarter

AstraZeneca Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat